[1]刘朝一,徐 伟,许正圆.基于价格指数的基本药物价格水平研究——以江苏省抗感染类药物为例[J].卫生经济研究,2020,(08):38-41.
 LIU Chao-yi,XU Wei,XU Zheng-yuan.Study on the Price Level of Essential Drugs Based on Price Index—— Take Anti-infective drugs in Jiangsu Province as an Example[J].Journal Press of Health Economics Research,2020,(08):38-41.
点击复制

基于价格指数的基本药物价格水平研究
——以江苏省抗感染类药物为例
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
期数:
2020年08期
页码:
38-41
栏目:
药械管理
出版日期:
2020-07-31

文章信息/Info

Title:
Study on the Price Level of Essential Drugs Based on Price Index
—— Take Anti-infective drugs in Jiangsu Province as an Example
作者:
刘朝一1徐 伟1许正圆1
1.中国药科大学国际医药商学院,江苏 南京 211198
Author(s):
LIU Chao-yiXU WeiXU Zheng-yuan
School of International Pharmaceutical Business ,China Pharmaceutical University,Nanjing Jiangsu 211198,China
关键词:
价格指数基本药物系统用抗感染类药物公立医疗机构
Keywords:
price indexessential drugssystemic use of anti-infective drugspublic medical institutions
分类号:
R95
文献标志码:
A
摘要:
目的:分析基本药物的价格水平及变化趋势。方法:以江苏省系统用抗感染类基本药物为例,计算2014—2017年帕氏、拉氏、费氏和链式费氏价格指数,分析药品价格水平及变化趋势。结果:江苏省系统用抗感染类基本药物的价格整体呈下降趋势,不同等级医疗机构的价格存在差异,基层医疗机构的价格最低且稳定。结论:规范公立医疗机构抗感染类基本药物的使用,着重监管和调控二级和三级医疗机构的药物剂型和规格,从多方面入手维持基本药物价格水平的相对稳定。
Abstract:
Objective To analyze the price level and changing trend of essential drugs.Methods Taking the anti-infective essential drugs in Jiangsu Province as an example,calculate the drug price indexes of Paasche,Laspeyres,Fisher and Chained Fisher from 2014 to 2017,and analysis the price level and changing trend.Results The price of anti-infective essential drugs for systematic use in Jiangsu Province shows a downward trend as a whole,the prices of different grades of medical institutions are different,and the prices of primary medical institutions are the lowest and stable.Conclusion Standardize the use of anti-infective essential drugs in public medical institutions,focus on supervising and regulating the dosage forms and specifications of secondary and tertiary medical institutions,and maintain the relatively stable price level of essential drugs from various aspects.

参考文献/References:

[1] 王淑玲,李飞立,王妍,等.关于我国药品价格综合指数的研究[J].价格理论与实践,2014(5):75-77.
[2] 吴晶,刘国恩.中国药品价格和数量指数及偏倚的实证分析[J].中国药物经济学,2011(1):7-17.
[3] 王淑庆. 药品成交指数编制方法研究[D].重庆大学,2013.
[4] 肖永红.我国细菌耐药控制需要“两步走、两手抓”[J].中国医学前沿杂志(电子版),2017,9(4):1-6.
[5] 屈晓远. 三级医院抗菌药物应用监测及规制实施效果研究[D].山东大学,2018.
[6] 韩煦,罗刚.基本药物包装规格存在的问题分析与建议[J].中国药事,2013,27(5):479-480,495.
[7] 吴玉霞,徐伟,蔡功杰,等.基本药物可获得性影响因素研究[J].卫生经济研究,2018(12):37-40.
[8] 陈斌斌,郝亚伟,董朝晖,等.药品价格指数在医保支付标准中的应用研究[J].中国卫生政策研究,2016,9(6):38-42.

相似文献/References:

[1]何常楠,傅鸿鹏.20种基本药物的集中采购价格分析[J].卫生经济研究,2016,(08):44.
[2]赵 静.应用层次分析法优化基本药物遴选的研究[J].卫生经济研究,2016,(12):13.
[3]王文杰,毛宗福,肖琳琪,等.贫困地区基层医疗机构基本药物供应保障研究[J].卫生经济研究,2018,(02):35.
[4]裴 婕,路 云,周 萍,等.瑞典基本药物目录的发展及启示[J].卫生经济研究,2018,(08):46.
 PEI Jie,LU Yun,ZHOU Ping,et al.The development and enlightenment of essential drug list in Sweden[J].Journal Press of Health Economics Research,2018,(08):46.
[5]杜雯雯,徐 伟,李孟林.南京市各级医疗机构用药结构和用药衔接性研究[J].卫生经济研究,2018,(09):26.
 DU Wen-wen,XU Wei,LI Meng-lin.Study on the Structure and Coherence of Drug Use in Medical Institutions at All Levels in Nanjing[J].Journal Press of Health Economics Research,2018,(08):26.
[6]吴玉霞,徐 伟,蔡功杰,等.基本药物可获得性影响因素研究——基于25省监测点数据的实证分析[J].卫生经济研究,2018,(12):37.
 WU Yu-xia,XU Wei,CAI Gong-jie,et al.Study on the Factors Affecting the Availability of Essential Drugs——An Empirical Analysis Based on Data from 25 Provinces[J].Journal Press of Health Economics Research,2018,(08):37.
[7]杜雯雯,徐 伟,蔡功杰.我国基本药物全额保障的实现路径研究[J].卫生经济研究,2018,(12):40.
 DU Wen-wen,XU Wei,CAI Gong-jie.Study on the Realizing Path of the Full Guarantee of Essential Medicines in China[J].Journal Press of Health Economics Research,2018,(08):40.
[8]尚兰成,常 峰,路 云.药价改革后我国药品价格形势分析——基于我国省际面板数据的实证研究[J].卫生经济研究,2019,(04):59.
 SHANG Lan-cheng,CHANG Feng,LU Yun.Analysis of China's Drug Price Situation after Drug Price Reform——An Empirical Study Based on Provincial Panel Data in China[J].Journal Press of Health Economics Research,2019,(08):59.
[9]张闪闪,吴 天,张 冉,等.2018年版《国家基本药物目录》调整解读[J].卫生经济研究,2019,(06):47.
 ZHANG Shan-shan,WU Tian,ZHANG Ran,et al.Interpretation of the 2018 Edition of the National Essential Drugs List[J].Journal Press of Health Economics Research,2019,(08):47.
[10]张迎春,丁俊杰,马光辉.考虑货币购买力的省域综合医疗服务价格差异分析[J].卫生经济研究,2021,38(8):66.
 ZHANG Ying-chun,DING Jun-jie,MA Guang-hui.Analysis on Price Differences of Provincial Comprehensive Medical Services Based on Purchasing Power of Money[J].Journal Press of Health Economics Research,2021,38(08):66.

更新日期/Last Update: 2020-07-31